Key Insights

Highlights

Success Rate

84% trial completion

Published Results

405 trials with published results (13%)

Research Maturity

1522 completed trials (49% of total)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

9.1%

281 terminated out of 3087 trials

Success Rate

84.4%

-2.1% vs benchmark

Late-Stage Pipeline

7%

219 trials in Phase 3/4

Results Transparency

27%

405 of 1522 completed with results

Key Signals

405 with results84% success281 terminated

Data Visualizations

Phase Distribution

2,189Total
Not Applicable (847)
Early P 1 (34)
P 1 (456)
P 2 (633)
P 3 (185)
P 4 (34)

Trial Status

Completed1,522
Unknown477
Recruiting432
Terminated281
Active Not Recruiting135
Withdrawn112

Trial Success Rate

84.4%

Benchmark: 86.5%

Based on 1522 completed trials

Clinical Trials (3087)

Showing 20 of 20 trials
NCT05632809Phase 2RecruitingPrimary

REStoring lymphoCytes Using NKTR-255* After chemoradiothErapy in Solid Tumors (RESCUE)

NCT07646041CompletedPrimary

Annual Brain MRI Surveillance for Detection of Brain Metastasis in Patients With Lung Cancer

NCT06051695Phase 1Recruiting

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

NCT07645222Phase 1Not Yet RecruitingPrimary

PHASE 1b STUDY OF HS-20122 COMBINED THERAPY IN NSCLC

NCT05483491Phase 1Recruiting

KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer

NCT00001823Recruiting

Evaluation for NCI Surgery Branch Clinical Research Protocols

NCT00597636Active Not RecruitingPrimary

Genetic Susceptibility to Lung Cancer in Never Smokers

NCT04262856Phase 2Completed

Study to Evaluate Monotherapy and Combination Immunotherapies in Participants With PD-L1 Positive Non-small Cell Lung Cancer

NCT02810262Completed

Association of Bone and Metabolic Parameters With Overall Survival in Patients With Bone Metastases From Adenocarcinoma Lung Cancer (POUMOS)

NCT05419076Phase 2RecruitingPrimary

A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain

NCT05403177Recruiting

Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)

NCT07638228Not ApplicableActive Not Recruiting

Evaluation of the Safety and Efficacy of a Wideband Electric Pulse Tumor Ablation System for Malignant Pulmonary Nodules

NCT07639242Phase 2Not Yet RecruitingPrimary

Olomorasib + Pembrolizumab KRAS G12C Mutant, PD-L1 TPS 1-49% Locally Advanced or Metastatic NSCLC

NCT06909201RecruitingPrimary

Hyperpolarized Xenon-129 Magnetic Resonance Imaging in Lung Cancer Patients Receiving Radiation Therapy for Investigating Radiation-response and Toxicity

NCT04093167Phase 2RecruitingPrimary

Study of CTDNA Response Adaptive Immuno-Chemotherapy in Lung Cancer

NCT05762731RecruitingPrimary

Screening for Lung Cancer in Subjects With Family History of Lung Cancer

NCT03637335Phase 3TerminatedPrimary

Comparing Palliative Radiotherapy With or Without Carboplatin

NCT06308120Not ApplicableActive Not Recruiting

A Trial to Compare Robotic Assisted Bronchoscopy Ion's Clinical Utility for Peripheral Lung Nodule Access and Diagnosis to ENB

NCT04748419Phase 1TerminatedPrimary

Safety & Efficacy of Consolidative Hypofractionated Radiation Therapy for Boosting Residual Lung Cancer With Durvalumab

NCT07513818Not ApplicableRecruitingPrimary

Implementing Low-dose ct Lung Cancer Screening in France.

Scroll to load more

Research Network

Activity Timeline